Clinical Trial Update: Autologous Muscle Derived Cells for Underactive Bladder [Phase 1]

View source ↗

Summary

Phase 1 trial assessing autologous muscle-derived cells for underactive bladder has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urinary Incontinence
• Urinary Retention

Drugs mentioned

• Autologous Muscle Derived Cells (autologous muscle-derived cells)

Snippet

Sponsor: Jason Gilleran | Conditions: Urinary Retention, Urinary Incontinence | Phase 1 | Status: COMPLETED | Results posted: 2022-01-19